Keyphrases
Clinical Trials
100%
Functional Impairment
100%
Subgroup Analysis
100%
Parent Report
100%
Responder Analysis
100%
Weiss Functional Impairment Rating Scale
100%
Attention Deficit Hyperactivity Disorder Medication
100%
Placebo
22%
Attention Deficit Hyperactivity Disorder
22%
Oppositional Defiant Disorder
22%
Lisdexamfetamine Dimesylate
22%
Guanfacine Extended-release
22%
Family Learning
11%
Social Activity
11%
Quality of Life Improvement
11%
Europe
11%
Negative Effects
11%
School Activities
11%
Clinically Significant
11%
Phase II Study
11%
Combined Type
11%
Minimal Clinically Important Difference
11%
Group Level
11%
Optimal Management
11%
Baseline Scores
11%
Non-responders
11%
Risky Behavior
11%
Pooled Analysis
11%
Phase III Clinical Trial
11%
Active Learning
11%
Symptomatic Improvement
11%
Family-school
11%
Activity Domains
11%
Seven-phase
11%
Difference Criterion
11%
Pivotal Trial
11%
Family Domain
11%
Medicine and Dentistry
Clinical Trial
100%
Functional Disease
100%
Attention Deficit Disorder
100%
Subgroup Analysis
100%
Rating Scale
69%
Placebo
15%
Oppositional Defiant Disorder
15%
Lisdexamfetamine
15%
Guanfacine
15%
Quality of Life
7%
Pooled Analysis
7%
Mathematics
Individual Patient
100%
Baseline Score
100%
Pivotal Trial
100%
Psychology
Attention Deficit Hyperactivity Disorder
100%
Functional Impairment
100%
Rating Scale
69%
Oppositional Defiant Disorder
15%
Quality of Life
7%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Placebo
40%
Oppositional Defiant Disorder
40%
Lisdexamfetamine
40%
Guanfacine
40%